Literature DB >> 24596781

Estimation of Circulating Immune Complexes in patients with Oral Leukoplakia and Oral Submucous Fibrosis: A Case Control Study.

Maheswari H1, Eswaran M A2, Srividhya S3, Malavika R4, Prabhu R5, Geetha K R5.   

Abstract

PURPOSE OF THE STUDY: The present study was conducted to estimate the serum levels of Circulating Immune Complexes in patients with Oral Leukoplakia ,Oral sub mucous fibrosis and normal subjects and correlate these values with the clinical grades of the diseases.
MATERIALS AND METHODS: The study consisted of 25 Oral Leukoplakia patients, 25 Oral sub mucous fibrosis patients and 25 Normal subjects.
RESULTS: The mean serum levels of CIC showed a gradual increase from normal subjects to Oral Leukoplakia patients and showed a high values in Oral sub mucous fibrosis patients. The mean serum levels of CIC also showed a gradual increase from clinical grade I to grade IV of Oral sub mucous fibrosis.
CONCLUSION: Serum levels of CIC may be taken as a prognostic marker for disease progression of patients with Oral Leukoplakia and Oral sub mucous fibrosis.

Entities:  

Keywords:  Poly Ethylene Glycol-6000 (PEG); Potentially malignant lesions and conditions; White lesions

Year:  2014        PMID: 24596781      PMCID: PMC3939558          DOI: 10.7860/JCDR/2014/7095.3967

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.

Authors:  S A Stanilova; E S Slavov
Journal:  J Immunol Methods       Date:  2001-07-01       Impact factor: 2.303

2.  Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.

Authors:  K Höffken; M R Price; V E Moore; R W Baldwin
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

3.  Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan.

Authors:  Ching-Hung Chung; Yi-Hsin Yang; Tung-Yiu Wang; Tien-Yu Shieh; Saman Warnakulasuriya
Journal:  J Oral Pathol Med       Date:  2005-09       Impact factor: 4.253

4.  Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers.

Authors:  P C Gupta; F S Mehta; D K Daftary; J J Pindborg; R B Bhonsle; P N Jalnawalla; P N Sinor; V K Pitkar; P R Murti; R R Irani; H T Shah; P M Kadam; K S Iyer; H M Iyer; A K Hegde; G K Chandrashekar; B C Shiroff; B E Sahiar; M N Mehta
Journal:  Community Dent Oral Epidemiol       Date:  1980       Impact factor: 3.383

Review 5.  Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer.

Authors:  R Pillai; P Balaram; K S Reddiar
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

Review 6.  Natural history of potentially malignant oral lesions and conditions: an overview of the literature.

Authors:  Séamus S Napier; Paul M Speight
Journal:  J Oral Pathol Med       Date:  2008-01       Impact factor: 4.253

7.  Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan.

Authors:  R Maher; A J Lee; K A Warnakulasuriya; J A Lewis; N W Johnson
Journal:  J Oral Pathol Med       Date:  1994-02       Impact factor: 4.253

8.  Leukoplakia of the labial commissure.

Authors:  W F Hogewind; I van der Waal
Journal:  Br J Oral Maxillofac Surg       Date:  1988-04       Impact factor: 1.651

9.  Comparison of immune derangements in patients with different malignancies.

Authors:  A Lichtenstein; J Zighelboim; F Dorey; S Brossman; J L Fahey
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

10.  Circulating Immune complexes (CIC) as marker for disease progress in oral cancer.

Authors:  Cynthia Jane; A V Nerurkar; F R Karjodkar
Journal:  Indian J Clin Biochem       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.